Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Chaigne

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Journal of Clinical Immunology|December 16, 2014
Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN diseaseFatima Dhalla, Sarah Murray, Ross Sadler, et al.
Journal of the American Academy of Dermatology|November 23, 2024
Diagnostic and prognostic performance of positron emission tomography/computed tomography in eosinophilic fasciitis: An observational multicenter retrospective studyKevin Chevalier, Jean-David Bouaziz, Matthieu Groh, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
Rheumatology (Oxford, England)|February 2, 2023
In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre studyBenjamin Chaigne, Kevin Chevalier, Athenaïs Boucly, et al.
Journal of Internal Medicine|June 28, 2023
Mouth opening in systemic sclerosis: A longitudinal analysis from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Christian Agard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 2017
STAT5B: A Differential Regulator of the Life and Death of CD4<sup>+</sup> Effector Memory T CellsSonia S Majri, Jill M Fritz, Alejandro V Villarino, et al.
Rheumatology (Oxford, England)|April 19, 2023
Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosisAëlle Le Gall, Trieu-Nghi Hoang-Thi, Raphaël Porcher, et al.
Journal of Autoimmunity|March 4, 2025
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Frédérique Aubourg, et al.
Journal of Autoimmunity|October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)François Barde, Kevin Chevalier, Paul Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2021
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment studyMarion Panhaleux, Olivier Espitia, Benjamin Terrier, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Journal of Clinical Immunology|December 16, 2014
Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN diseaseFatima Dhalla, Sarah Murray, Ross Sadler, et al.
Journal of the American Academy of Dermatology|November 23, 2024
Diagnostic and prognostic performance of positron emission tomography/computed tomography in eosinophilic fasciitis: An observational multicenter retrospective studyKevin Chevalier, Jean-David Bouaziz, Matthieu Groh, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
Rheumatology (Oxford, England)|February 2, 2023
In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre studyBenjamin Chaigne, Kevin Chevalier, Athenaïs Boucly, et al.
Journal of Internal Medicine|June 28, 2023
Mouth opening in systemic sclerosis: A longitudinal analysis from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Christian Agard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 2017
STAT5B: A Differential Regulator of the Life and Death of CD4<sup>+</sup> Effector Memory T CellsSonia S Majri, Jill M Fritz, Alejandro V Villarino, et al.
Rheumatology (Oxford, England)|April 19, 2023
Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosisAëlle Le Gall, Trieu-Nghi Hoang-Thi, Raphaël Porcher, et al.
Journal of Autoimmunity|March 4, 2025
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Frédérique Aubourg, et al.
Journal of Autoimmunity|October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)François Barde, Kevin Chevalier, Paul Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2021
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment studyMarion Panhaleux, Olivier Espitia, Benjamin Terrier, et al.
Pageof 11